Indeed, BAFF has effects on T cell proliferation, cytokine production, and differentiation (85, 86), so although T cell depletion does not occur following BEL administration (87), interference with T cell function and differentiation may have enough of an effect to control SLE disease activity. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.